Viscira, a leading provider of interactive, new-media communication and technology solutions for the life sciences industry, today announced the release of its Version 2.0 vDetail solution. With multiple features, this interactive selling tool adds new, dynamic content options for use with Veeva iRep, the Apple iPad application that combines the power of Veeva CRM with closed loop marketing (CLM). This enables sales reps using iRep to deliver even more engaging and impactful content to increase meeting effectiveness.
Viscira has developed a solution that cohesively integrates rich, immersive content and unique interactivity into Veeva iRep. These dynamic content modules include high-fidelity 3D animations with real-time 3D content, next-generation video with sophisticated motion graphics treatments, interactive patient case builder applications, and interactive gaming components.
“Viscira is taking interactive content to the next level from a creative perspective, all fully leverageable within Veeva iRep ” explains Dave Gulezian, President and CEO of Viscira. “Customers have asked for new ways to maximize customer engagements and further differentiate themselves in the market. Our new vDetail solution enables them to deliver key brand and educational messages in more impactful ways while continuing to fully leverage iRep’s advanced capabilities.”
“Viscira’s vDetail is a great example of innovation by one of our Veeva Web partners, whose solution works seamlessly with Veeva iRep,” said Tim Murphy, Director of Multichannel Marketing at Veeva Systems. “Viscira’s solution delivers high impact content using iRep, further enhancing sales interactions through multichannel CLM.”
Viscira’s vDetail is yet another example of how Viscira is capitalizing on the growing trend of tablet usage by physicians, patients and life sciences companies. The company continues to see strong demand for its distinctive mobile apps, and will continue to fully leverage its software development expertise and unique production capabilities to make further advancements in this area.